An updated look at the world of formularies Sep 1, 2006 By:
Tony Pinsonault

|
Formularies, like managed care in general, are in a constant state of evolution.

Eight ways to penetrate the over -65 market Dec 1, 2007 By:
Tony Pinsonault

|
The implementation of the new Medicare Part D prescription-drug benefit in 2006 helped create a "perfect storm" for U.S. pharmaceutical and biotechnology manufacturers.

The case for a new understanding of formularies May 1, 2007 By:
Bill Barr

|
Formularies are often described using terms such as "open," meaning all products are available, and "closed," meaning that only certain products are available. However, given the complex nature of pharmacy-benefit design, these terms are inadequate as labels to describe formularies.

Selling pharmaceuticals under the Physician Data Restriction Program Feb 1, 2007 By:
Gwen McLean

|
Your ability to view prescribing data is minimal.

Do you know who pays for your products? Jan 1, 2007 By:
Bill Barr

|
To maximize sales in a managed care environment, pharmaceutical representatives must identify the "true payers" who assume the financial risk for their products.

What you need to know now that Part D is reality Jun 1, 2006 By:
Tony Pinsonault
|
What you need to know now that Part D is reality.

The way physicians are compensated can influence prescribing Mar 1, 2006 By:
Christian Pinsonault, Tony Pinsonault

|
When reps understand how physicians are paid, they gain insights into how financial factors influence prescribing behavior. Then they can fine-tune their messages to help address physician needs while ensuring appropriate utilization of their products.

What you need to know about the new Medicare Part D benefit plans Dec 1, 2005 By:
Tony Pinsonault, Christian Pinsonault

|
What you need to know about the new Medicare Part D benefit plans.

A Q&A with Richard Stefanacci Nov 1, 2005 By:
Susan Vargas
|
A Q&A with Richard Stefanacci.
